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Abstract
A travel medicine clinic is the proper medical centre aimed to provide updated recom-
mendations before any journey. The study aim was to assess the number of accesses dur-
ing 2016 at the Travel Medicine Clinic of the Local Health Unit in the Umbria Region. 
An electronic ad hoc database was developed. Paper-based data referring to 2016 were 
recorded in this electronic registry, developed on Microsoft Office Access®. In 2016, 891 
subjects came in our clinic in order to get information before travelling. In our sample, 
53.3% were male and the mean age was 35.33 years ± 0.58. Almost half had a higher 
education, and 20% were foreign. Vaccines against food- and water-borne diseases were 
the most frequently administered. Approximately, 74% of the attenders were suggested 
to do an anti-malaria prophylaxis (Mefloquine in one-half, approximately). Every travel-
ler received a pre-travel counselling. Performance activity of our clinic and the adherence 
to preventive protocols in case of international travels, have been assessed. 
INTRODUCTION
Over time, the rapid circulation of people and the low 
cost of travelling are increasing the chances of travel-
ling. In particular, according to the World Economic 
Outlook of October 2017 by the International Mon-
etary Fund, the improvement of economic conditions 
plays a role in increasing both the business and leisure 
travels [1]. World Tourism Organization data have 
shown a growth in the number of international travels 
with 1,237 million in 2016 and an estimated increase 
between +3/+4% for 2017 [2]. However, international 
travels can represent a potential health risk depending 
on the duration, type of travel, destination and health 
status. Health risks associated to travelling are both in-
fective and traumatic [3] including poisoning [4]. Actu-
ally, accident is the first cause of death among travellers, 
whilst infectious diseases, contracted while travelling, 
could represent a risk of disease spread also in the coun-
try of origin. This is particularly true considering both 
incubation and emerging/re-emerging of new diseases, 
such as Ebola [5], Zika [6] or Plague [7]. In the major-
ity of cases, these risks are behaviour related and pre-
ventable. Prevention could be obtained both reducing 
the exposure to risk factors and through vaccination. 
Periodically, WHO provides and updates data on the 
distribution of the diseases in the world and, simulta-
neously, the countries where the vaccine against yellow 
fever is mandatory, as well as all the vaccinations recom-
mended for each country [8]. 
A travel medicine clinic is the proper medical centre 
aimed to provide updated recommendations before any 
journey. According to WHO guidelines, medical consul-
tation before travelling must identify any possible travel-
ler’s health need related to the destination and duration 
of the journey. In particular it should provide vaccina-
tion recommendations and anti-malaria prophylaxis. 
The physician, with the travellers, should investigate the 
sanitation conditions of the destination and empower 
the travellers on how to best protect themselves from 
the risk of acquiring diseases. Moreover, vaccination 
schedules should be tailored according to the immuni-
zation status, destination and type of the journey. 
In Italy, the National Institute of Statistics (Istat) es-
timates that the trips made by Italian citizens amount-
ed to about 66 million, in 2016 [9]. In 17.2% of the 
cases, trips were in foreign countries. Looking at the 
extra-European destinations, United States, Tunisia 
and China were the most visited countries in 2016 [9]. 
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Analysing the travel reasons, 90% of all trips took place 
for holidays while 10% for business. Nevertheless, trips 
abroad are carried out mainly for cultural, monumental 
and archaeological reasons (30.6%) [9].
We analysed data of the Travel Medicine Clinic of the 
Local Health Unit 1 (LHU) in Umbria Region, autho-
rized by Ministry of Health. In particular, the study aim 
was to assess the number and type of accesses during 
the year 2016. Moreover, travellers’ demographics char-
acteristics, travel and health information were collected.
METHODS
Travel medicine clinic LHU1, located in Perugia, pro-
vides medical advices and vaccination counselling before 
travelling for a catchment area of 497 381 people. Dur-
ing the consultation, the physician collects information 
related both to the travel and the individual, regarding 
immunization status, health condition, and pharmaco-
logical history. In particular: i) demographic character-
istics (age, sex, educational level, job and country of 
origin); ii) travel information (date of departure, dura-
tion, destination, purpose, type of accommodation); iii) 
health history (chronic diseases if any, allergies, adverse 
events associated to food, antibiotics or other vaccines, 
pregnancy, breastfeeding and pharmacological therapy); 
iv) immunization status (vaccination performed in the 
past). Moreover, the physician provides information re-
lated to the most important health risks associated to the 
travel. In particular, specific factors are taken in account 
such as destination, duration of travel, purpose of travel, 
level of sanitation in the accommodation area and health 
status of subjects, according to WHO recommenda-
tions. Informative sheets on vector-borne diseases, such 
as food- and water-borne diseases are offered to all the 
travellers. Different types of anti-malaria prophylaxis, if 
needed, are discussed with the subjects. Until this study, 
all the data were collected on paper. We then developed 
an electronic database, which has been designed and 
organized ad hoc. Paper-based data referring to 2016 
were recorded in this electronic registry, developed on 
Microsoft Office Access®. Statistical analysis was per-
formed using STATA SE/12®. In order to facilitate the 
occupational comparability, we classified our sample 
according to the International Standard Classification 
of Occupations 2008 (ISCO-08). In Italy, there are no 
national data related to travellers: that means no infor-
mation available on total people who go on a journey per 
year. Due to the absence of an established denominator, 
we calculated the rate of access considering the inhabit-
ants, disaggregated for age class and gender, living in 
catchment area of our clinic. In order to evaluate the yel-
low fever vaccination adherence, according to the WHO 
country list, we considered as countries with required 
vaccination certificate the following [8]: Angola, Benin 
Burkina Faso, Cameroon, Congo, Democratic Republic 
of the Congo, Côte D’Ivoire, French Guiana, Gabon, 
Ghana, Guinea Bissau, Liberia, Mali, Niger, Rwanda, 
Central African Republic, Sao Tome, Togo.
RESULTS
During the time period from 1st January 2016 to 31st 
December 2016, 891 subjects came to our travel medi-
cine clinic in order to get information before travelling. 
In our sample, 53.3% were male and the mean age was 
35.33 years ± 0.58. Supplementary material 1 (available 
online) shows socio-demographic characteristics of the 
individuals. Supplementary material 2 (available online) 
represents access rate x 1,000 inhabitants, according 
to age and gender. Almost half (48.2%) of the subjects 
were either graduated or took a postgraduate licence 
(higher education). In our sample, 179 people out of 
891 had at least one chronic disease and the most fre-
quent was cardio-vascular disease (62 travellers, data 
not shown). Twenty percent of the people were for-
eign. Ivory Coast, Cameroon and Nigeria were the 
most common countries of origins among the foreign 
travellers attending our clinic, in 2016. Figure 1 details 
the countries of origin, while Supplementary material 3 
(available online) specifies the travel reasons. Actually, 
the first three reasons are tourism, business and visit-
ing friends and relatives, respectively in 29.41%, 18.07% 
and 17.06% of cases. Other characteristics of journeys 
are shown in Supplementary material 4 (available online). 
Table 1 shows the type of vaccination and the respec-
tive dosage, according to the vaccine schedules. More-
over, we performed 214 yellow fever vaccines in people 
travelling to destinations with no requirement of yellow 
fever vaccination certificate. Approximately, 74% of the 
attenders were suggested to do an anti-malaria prophy-
laxis. Looking at the chemoprophylaxis, in the majority 
of cases (47.9%), travellers preferred Mefloquine, fol-
lowed by Atovaquone-Proguanil (11.7%). However in 
the 21.4% only a behavioural prophylaxis was suggested 
and in 10.2% both behavioural and auto medication 
(data not shown). The highest flow of people attending 
the clinic, as expected, was during the summer (May, 
June and July) and before the Christmas period (De-
cember), with a mean access of 97 people per month, 
compared to 63 people/month during the remaining 
months (data not shown). 
DISCUSSION
In this retrospective study, we present data available 
at the Travel Medicine Clinic in LHU Umbria 1, Pe-
rugia. Data presented in this paper display the picture 
of travellers attending the travel medicine clinic and 
the activity performance of the clinic. In our study, the 
regular users are young people, male, and with high-
er education. Moreover, we moved paper-based data 
to a more efficient electronic archive. About 20% of 
our population is foreign, in accordance with previ-
ous studies, also conducted in Italy [10, 11]. Approxi-
mately 49% of attenders were 21-40 years old. These 
data are in line with the previous publication referred 
to the Italian population [9]. Actually, people aged 21-
60 years were also the users with the highest number 
of accesses per year. Among 66 users who attended the 
clinic twice during 2016, 49 were 21-60 years. More in 
detail, 24 subjects were aged 21-40 years, while 25 were 
aged 41-60 years. Regarding the health status, the ma-
jority of travellers were healthy, however approximately 
20% had at least one chronic disease, whilst 3.5% had 
an allergy and 2 women were pregnant. The average 
length of stay was 58.06 days. Students, Professionals 
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and Agricultural, Forestry, Fishery and Craft workers 
were the categories of workers who spent more time 
abroad. In particular, 53 students stayed abroad more 
than one month, as well as 35 Professionals and 25 of 
the Agricultural, Forestry, Fishery and Craft workers. 
Furthermore, the same three groups are those who 
came to the travel clinic earlier, related to the date of 
departure: 61 students, 45 professionals and 32 among 
agricultural, forestry, fishery and craft workers consult-
ed the clinic at least 30 days before the departure. In 
our analysis, people attended the travel clinic 38 days 
before the departure, according with the WHO recom-
mendation that suggests the consultation 4-8 weeks 
before any journey. Ivory Coast, Peru, Nigeria and 
Thailand are the preferred destinations. In addition, 
China and Brazil are chosen respectively in the 3.85% 
and 3.75% of our travellers. These results are slighting 
different compared to the national data, where China, 
Tunisia and United States are the three preferred coun-
tries among Italian people [9]. Comparing the travel’s 
Table 1
Vaccines’ injections and appropriate dosage according to schedules
Vaccine Dosage 
1st dose 2nd dose 3rd dose 4th dose 5th dose
HAV 516 118 5
HAV + HBV 56 46 30
HBV 29 15 15 3
Yellow fever 325 11
Rabies 15 11 10 5 3
Men B 18 14
Men C 2
Men ACWY 207 6
Japanese encephalitis 3 3
Typhus (oral) 560 65 17 6 1
Typhus (i.m.) 10 1
Cholera 568 26 4
Diphtheria-Tetanus 143 9 3
Poliomyelitis 34 3 3 3
a) 
 
b) 
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Figure 1
a) Countries of origins of travellers attending the Travel medicine clinic LHU1, Perugia. The figure shows the most common coun-
tries among the 178 foreigner travellers, in 2016.
b) Countries of destination.
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reasons obtained in our study with Istat data, we also 
confirm the prevalence of travels due to tourism, fol-
lowed by business [9].
In May 2014, the WHO’s Strategic Advisory Group 
of Experts on immunization stated the life-long pro-
tection of one dose of yellow fever vaccine. However, 
the legal application of this amendment was on 11 July 
2016. After this, we stopped performing the booster 
doses of yellow fever vaccine every 10 years. Actually, 
our immunization data reflect this change, with only 
11 doses of yellow fever booster performed before July 
2016 [12]. Among the destinations chosen by our trav-
ellers, even though 214 did not have the requirement 
for yellow fever vaccination, travellers accepted the yel-
low fever vaccine. In particular, travellers directed to 
Peru (32 subjects, 14.95%), Brazil (28 people, 13.08%) 
and Niger (28 subjects, 13.08%) performed the vaccine.
Regarding Malaria, in Italy approximately 2/3 of 
imported cases occurred among immigrants visiting 
friends and relatives [13, 14]. Often, immigrants under-
estimated the risk of malaria infection during travels in 
their own countries, especially in Africa [15]. In order 
to prevent imported cases, we suggested a prophylaxis 
in more than 70% of our sample. During the counsel-
ling, we stressed the importance to combine chemo-
prophylaxis with personal protective measures due to 
the fact that antimalarial drugs do not guarantee 100% 
protection. Even though malaria prevention is country-
specific, also the drugs interactions and the patients’ 
preference need to be taken into account. The major-
ity of travellers in our sample preferred Mefloquine, in 
contrast with a previous study, where the preferred drug 
was Atovaquone-Proguanil [10]. Probably this differ-
ence could be due to the longer average length of stay: in 
the study performed by Troiano et al. the average length 
of stay was 36.17 days compared to our study, where 
it was 58.06 days [10]. According to the Centers for 
Disease Control and Prevention (CDC), Mefloquine 
should be preferred for long trips. In our case, people 
favoured a weekly drug assumption instead of a daily 
one. Moreover, Mefloquine is the cheapest alternative, 
especially if compared to Atovaquone-Proguanil. On 
the other hand, Doxycycline was not the first choice 
probably because in the majority of the cases travellers 
had planned a sun exposure, and this drug can increase 
the risk of sun sensitivity; moreover Doxycycline cannot 
be prescribed in children and needs to be taken daily for 
4 weeks after returning home.
CONCLUSION
In conclusion, our results present data on the so-
ciodemographic characteristics of Umbrian travellers, 
information about the destinations and type of jour-
neys. This analysis allowed to assess the performance 
activity of our clinic, and to measure the adherence to 
the preventive protocol in case of international travels. 
The high number of yellow fever vaccines performed in 
travellers without compulsory indication, suggests the 
importance of the travel medicine clinic. In particular, 
these data highlight the central role played by the coun-
selling for immunization and for all the behavioural 
prophylaxis. Nevertheless, some issues have to be taken 
into account when interpreting these results. Actually, 
due to the absence of an established denominator (total 
number of travellers), we could not estimate the realis-
tic impact of our clinical activity.
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